Larry Ellberger is Director at Celldex Therapeutics, Inc. (CLDX). They have made 7 open-market trades across 1 company since 2009, most recently 2017-06-15.
CIK 0001219551
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $375K since 2009, against 1 sale. Across 6 scored buys the stock is down 1.6% at ninety days, and 1.8 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -29.9% | -1.6% | -1.6% |
| Alpha | -24.1% | -1.8% | -1.8% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLDX | BUY | 2015-08-25 | 2015-08-26 | $14.00 | $70K | -29.9% | -1.6% | -1.6% |
| CLDX | BUY | 2015-08-20 | 2015-08-21 | $15.00 | $75K | -29.9% | -1.6% | -1.6% |
| CLDX | BUY | 2015-08-18 | 2015-08-19 | $15.95 | $80K | -29.9% | -1.6% | -1.6% |
| CLDX | BUY | 2015-08-13 | 2015-08-14 | $16.59 | $83K | -29.9% | -1.6% | -1.6% |
| CLDX | SELL | 2013-12-06 | 2013-12-10 | $24.50 | $434K | -29.9% | -1.6% | -1.6% |
| CLDX | BUY | 2009-11-30 | 2009-11-30 | $4.47 | $22K | -29.9% | -1.6% | -1.6% |
| CLDX | BUY | 2009-11-30 | 2009-11-30 | $4.50 | $45K | -29.9% | -1.6% | -1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.